A less invasive valve replacement for a failing heart valve
Part of Heart & circulation clinical trials.
This trial is testing a new valve that can be placed inside your old, failing heart valve using a thin tube (catheter) – a less invasive approach than another open-heart surgery. It may help if your current valve is too risky to operate on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have had a previous heart valve replacement (a tissue valve) that is no longer working properly – either narrowed or leaking.
- You are experiencing symptoms such as shortness of breath, chest pain, or fatigue, classified as NYHA class II or higher.
- You are considered high risk for another open-heart surgery, or surgery is not an option for you.
- Your anatomy is suitable for a new valve placed through a catheter (a less invasive approach).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests Prizvalve, a catheter-based procedure to replace a severely damaged “atrioventricular” valve in people at high risk from open-heart surgery. It may help reduce symptoms caused by valve narrowing or leaking when traditional surgery is not a good option.
This trial studies Prizvalve Pro™, a new transcatheter (catheter-based) aortic valve replacement, for people with severe aortic valve narrowing who are too high-risk for standard surgery. It may help your heart work better and improve symptoms by replacing the failing valve without open-heart surgery.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
This trial tests a new, less invasive replacement valve for people whose mitral heart valve is failing. The goal is to improve blood flow and reduce symptoms like shortness of breath without the need for major open-heart surgery.
This study tests a biological (tissue) heart valve replacement system designed to be easier to change later. It may help people who need valve surgery because their valve is narrowed or damaged.
This early-stage trial tests a new device called the ReValve System that replaces a damaged mitral valve (the valve that controls blood flow in your heart). The study is for people with a weakened heart who have leaking mitral valves and are experiencing heart failure symptoms.
Hear when a new Failing Bioprosthetic Valves trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.